Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00665184 · ClinicalTrials.gov registry record · NA
Strength Training and Medication Effects in Parkinson Disease Effects on Hypokinesia in Parkinson Disease
A NA study of Parkinson Disease, sponsored by University of Utah.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
- 1
- Study location
NCT00665184: Completed NA study of Parkinson Disease, sponsored by University of Utah.
NCT00665184 is a NA study of Parkinson Disease that has completed, run by University of Utah. The registered enrollment target is 41 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00665184, a NA study of Parkinson Disease, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
- 1
- Study location
Study Summary
Parkinson disease is a degenerative neurologic condition characterized by slowness of movement, tremor, and loss of balance control. It results in significant degrees of disability for affected individuals. Exercise and medication management are two treatments frequently used to treat Parkinson disease, and although some individuals benefit from these treatments, by what effect exercise works is presently not known. We will examine muscle structure and movement control responses to strengthening exercises and compare them to the therapeutic response observed as a result of medication intake. This process will allow us to better understand the mechanisms underlying the therapeutic effects of strengthening exercise for persons with Parkinson disease.
Conditions Studied
Interventions
- BEHAVIORAL Resistance Exercise via Negative Eccentric Work
- BEHAVIORAL Standard care exercise training
Study Locations (1)
Utah
- University of Utah Health Sciences Center - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2007-08 |
| Est. Completion | 2011-07 |
| Phase | NA |
What the finished NCT00665184 record still lists
NCT00665184 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 2 interventions - of which Resistance Exercise via Negative Eccentric Work is the first listed.
NCT00665184 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT00665184 about?
NCT00665184 is a clinical study titled "Strength Training and Medication Effects in Parkinson Disease Effects on Hypokinesia in Parkinson Disease". Parkinson disease is a degenerative neurologic condition characterized by slowness of movement, tremor, and loss of balance control. It results in significant degrees of disability for affected individuals. Exercise and medication management are two treatments frequently used to treat Parkinson dise...
What is the current status of trial NCT00665184?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2007-08. Estimated completion is 2011-07.
What conditions does trial NCT00665184 study?
This clinical trial studies the following conditions: Parkinson Disease.
What interventions are being tested in trial NCT00665184?
The interventions under investigation include: Resistance Exercise via Negative Eccentric Work (BEHAVIORAL), Standard care exercise training (BEHAVIORAL).
Who is sponsoring clinical trial NCT00665184?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00665184 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00665184's enrollment target sits among peer trials
41 171st of 297 higher than 126 of 297 other Parkinson Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Parkinson Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease
RECRUITING · NA
-
Neocortical Microarchitecture of Executive Function
RECRUITING · NA
-
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
RECRUITING · NA
-
Neurophysiology of Reward Signaling in Parkinson's Disease
RECRUITING · NA
-
Balance Tele-Rehab in Parkinson's Disease Parkinson's Disease
RECRUITING · NA
-
Rock Steady Boxing: A Community Based In Person Class
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia